Control of cardiovascular disease risk factors among patients with type II diabetes in a primary-care setting in Beijing

Journal of the American Society of Hypertension

Volumn 12, Issue 2, 2018, Pages 128-134

  Zuo, Hui Juan ^a   Wang, Wen Hua ^a   Deng, Li Qun ^a   Su, Jiang Lian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; control rate; diabetes; risk factor

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING;

EID: 85039149597     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2017.12.006     Document Type: Article

References (28)

1. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010. Lancet 380 (2012), 2095–2128.
2. Murray, C.J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010. Lancet 380 (2012), 2197–2223.
3. Danaei, G., Lawes, C.M., Vander Hoorn, S., Murray, C.J., Ezzati, M., Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration. Lancet 368 (2006), 1651–1659.
4. Levey, A.S., Coresh, J., Chronic kidney disease. Lancet 379 (2012), 165–180.
5. Investigation Group for Chronic Diabetic complications Chinese Diabetes Society Chinese Medical Association. A nationwide retrospective analysis on chronic diabetic complications and related macrovascular disease of in-patients with diabetes during 1991-2000. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24 (2002), 447–451.
6. Hu, D., Fu, P., Xie, J., Chen, C., Yu, D., Whelton, P.K., et al. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults. Diabetes Res Clin Pract 81 (2008), 250–257.
7. Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 362 (2010), 1090–1101.
8. Xu, Y., Wang, L., He, J., Bi, Y., Li, M., Wang, T., et al. Prevalence and control of diabetes in Chinese adults. JAMA 310 (2013), 948–958.
9. 2016 European guideline on cardiovascular disease prevention in clinical practice. Int J Behav Med 24 (2017), 321–419.
10. Ismail-Beigi, F., Moghissi, E., Tiktin, M., Hirsch, I.B., Inzucchi, S.E., Genuth, S., Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med 154 (2011), 554–559.
11. Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38 (2015), 140–149.
12. Chinese Diabetes Society (CDS). Guideline for prevention and treatment of type 2 diabetes in Chinese. Zhonghua Tang Niao Bing Zazhi 6 (2014), 447–496.
13. Mostaza-Prieto, J.M., Martín-Jadraque, L., López, I., Tranche, S., Lahoz, C., Taboada, M., et al. Evidence-based cardiovascular therapies and achievement of therapeutic goals in diabetic patients with coronary heart disease attended in primary care. Am Heart J 152 (2006), 1064–1070.
14. Mengual, L., Roura, P., Serra, M., Montasell, M., Prieto, G., Bonet, S., Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia. Cardiovasc Diabetol, 9, 2010, 14.
15. Ji, L., Hu, D., Pan, C., Weng, J., Huo, Y., Ma, C., et al. Primacy of the 3B approach to control risk factor for cardiovascular disease among type 2 diabetes. Am J Med 126 (2013), e11–e22.
16. Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults and the proportion of adults who work in a smoke-free environment–United States, 1999. MMWR Morb Mortal Wkly Rep 49 (2000), 978–982.
17. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 44 (2016), 833–853.
18. Wu, Y., Liu, X., Li, X., Li, Y., Zhao, L., Chen, Z., et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 114 (2006), 2217–2225.
19. Li, M.Z., Ji, L.N., Meng, Z.L., Guo, X.H., Yang, J.K., Lu, J.M., et al. Management status of type 2 diabetes mellitus in tertiary hospital in Beijing: gap between guideline and reality. Chin Med J (Engl) 125 (2012), 4185–4189.
20. Orozco-Beltrán, D., Gil-Guillen, V.F., Quirce, F., Navarro-Perez, J., Pineda, M., Gomez-de-la-Cámara, A., et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain. Int J Clin Pract 61 (2007), 909–915.
21. Li, X., Xu, Y., Li, J., Hu, D., The Gender differences in baseline characteristics and statin intervention among outpatients with coronary heart disease in China, the China Cholesterol Education Program. Clin Cardiol 32 (2009), 308–314.
22. Gao, F., Zhou, Y.J., Hu, D.Y., Zhao, Y.X., Liu, Y.Y., Wang, Z.J., et al. Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China. PLoS One, 8, 2013, e47681.
23. Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta–analysis individual participant death from randomized trials. Lancet 373 (2009), 1849–1860.
24. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of trials of antiplatelet therapy for prevention of death myocardial infarction and stroke in high risk patients. BMJ 324 (2002), 71–86.
25. American Diabetes Association. Executive summary: standards of medical care in diabetes-2014. Diabetes Care 37:suppl (2014), S14–S80.
26. State Council of People's Republic of China. Recent priority implementation programs of the health care system reform. 2007 Available at http://www.gov.cn/ztzl/gclszfgzbg/content_554887.htm. Accessed December 22, 2017.
27. Ministry of Health, People's Republic of China. On the issuance of “National Basic Public Health Services Specification (2011 edition)”. 2012 Available at. http://www.nhfpc.gov.cn/cmsresources/mohfybjysqwss/cmsrsdocument/doc12006.doc. Accessed December 22, 2017.
28. Luo, X., Liu, T., Yuan, X., Ge, S., Yang, J., Li, C., et al. Factors influencing self-management in Chinese adults with type 2 diabetes: a systematic review and meta-analysis. Int J Environ Res Public Health 12 (2015), 11304–11327.